Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes
- 1 October 1999
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 138 (4) , S276-S286
- https://doi.org/10.1053/hj.1999.v138.a100463
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Outcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management StrategyNew England Journal of Medicine, 1998
- Mortality and Risk Indicators for Death during Five Years after Acute Myocardial Infarction among Patients With and Without ST Elevation on Admission ElectrocardiogramCardiology, 1997
- Can ECG Changes Predict the Long-Term Outcome in Patients Admitted to Hospital for Suspected Acute Myocardial Infarction?Cardiology, 1997
- Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients With Unstable AnginaJAMA, 1996
- Recognition and Treatment of Unstable AnginaDrugs, 1996
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineNew England Journal of Medicine, 1995
- Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.Circulation, 1994
- Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.Circulation, 1994
- Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992